ENTITY
Bloomage Biotechnology

Bloomage Biotechnology (963 HK)

30
Analysis
Materials • China
Bloomage Biotechnology is a global biotechnology and biomaterial company specializing in the research, development, production, and application of bioactive substances, primarily hyaluronic acid and its derivatives. These products serve the pharmaceuticals, medical devices, cosmetics, and food/nutrition industries. The company was founded in 2000 and is headquartered in Jinan, Shandong, China.
more
bullish•Giant Biogene
•03 Aug 2022 09:15

Giant Biogene Pre-IPO - The Positives - Fast Growth and Juicy Margins

Giant Biogene aims to raise around US$500m in its Hong Kong IPO. It is a leader in the recombinant collagen market in China.

Logo
722 Views
Share
bullish•Yatsen Holding Ltd
•19 Nov 2020 20:09

Yatsen IPO Trading - A Little More Pricey Now

Yatsen Holding raised around US$617m in its US IPO, by pricing its IPO at the top-end of its range. The company is backed by Hillhouse, Tencent and...

Logo
623 Views
Share
bullish•Smartkarma
•24 Jun 2017 18:20

Last Week, in Event SPACE (24 June 2017)

In this note, CWT Ltd (CWT SP)’s deal completion probability slides on HNA Group's alleged oversight; PCCW Ltd (8 HK)’s net cash stub looks...

Logo
500 Views
Share
bearish•EC Healthcare
•02 Mar 2016 16:45

Union Medical IPO - We Would Avoid on Slowing Growth and Disclosure Concerns

Union Medical Healthcare (UMH), an aesthetic medical services provider in Hong Kong, plans to raise upto US$120m through an issuance of primary...

Logo
527 Views
Share
bearish•EC Healthcare
•25 Feb 2016 17:07

Union Medical Healthcare Pre-IPO Review - Dressed up with More than Its Fair Share of Botox

Union Medical Healthcare, the largest provider of aesthetic medical services in Hong Kong, plans to raise US$150m through its IPO in Hong Kong. As...

Logo
813 Views
Share
x